Projects per year
Personal profile
Education
- 2007 DPhil (Physiology and Genomics), University of Oxford
- 2001 M.S., Department of Pharmacology, National Cheng Kung University
- 1999 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2018.05- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
- 2018.01- Vice Dean, College of Pharmacy, Taipei Medical University
- 2015.08- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2012.08-2015.07 Associate Professor, School of Pharmacy, Taipei Medical University
- 2015.08- Associate Professor, Ph.D Program for Translational Medicine, Taipei Medical University
- 2013.08- Associate Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
- 2013.08-2019.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2013.08- Associate Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
- 2012.10-2013.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2012.08- Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
- 2016.04-2017.04 Secretary General, The Pharmaceutical Society of Taiwan
- 2009.02-2012.07 Assistant Professor, Kaohsiung Medical University
- 2002.09-2003.10 Deputy Administrator, Food and Drug Administration of Taiwan
Research Interests
- Genetic characterization of calcium channel related genes to establish personalized therapy
- Molecular identification for human genetic variants and drug responses
Awards
- 2019 Research Dissertation Award - Excellence Award, Taipei Medical University
Fingerprint Dive into the research topics where Wei-Chiao Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
進展性胰臟癌新穎增進免疫療法的治療策略與生物指標-對免疫療法併用方案節拍式化療或射頻燒灼療法之胰臟癌患者進行基因標記和免疫基因組庫之鑑定與分析(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
利用藥物基因體發展急性登革熱病毒感染期間免疫反應之臨床診斷：探討T細胞組庫和C-型凝集素基因家族之遺傳變異(1/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
利用大型基因資料庫及臨床收案，探討台灣族群ITPKC基因變異在氣喘之角色
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
2-1-3 精進核心研究服務平台-胃腸道腫瘤精準醫療奈米與免疫指標暨療法開發
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
Mechanism Study of Non-Alcoholic Fatty Pancreas Disease and Construction of Druggable Targets( III )(3/3)
6/1/19 → 11/30/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond
Sung, P. S., Chang, W. C. & Hsieh, S. L., Jan 1 2020, Advances in Experimental Medicine and Biology. Springer India, p. 57-73 17 p. (Advances in Experimental Medicine and Biology; vol. 1204).Research output: Chapter in Book/Report/Conference proceeding › Chapter
1
Citation
(Scopus)
Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
Wei, J. C. C., Chang, W. C. & Mushiroda, T., Aug 13 2020, In : Frontiers in Pharmacology. 11, 1239.Research output: Contribution to journal › Editorial
Open Access
Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents
Irham, L. M., Chou, W. H., Calkins, M. J., Adikusuma, W., Hsieh, S. L. & Chang, W. C., Aug 20 2020, In : Biochemical and Biophysical Research Communications. 529, 2, p. 263-269 7 p.Research output: Contribution to journal › Article
Open Access
1
Citation
(Scopus)
HSPB1 rs2070804 polymorphism is associated with the depth of primary tumor
Hung, C. S., Huang, C. Y., Hsu, Y. W., Makondi, P. T., Chang, W. C., Chang, Y. J., Wang, J. Y. & Wei, P. L., Jan 1 2020, In : Journal of Cellular Biochemistry. 121, 1, p. 63-69 7 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
Huang, C. M., Huang, M. Y., Huang, C. W., Tsai, H. L., Su, W. C., Chang, W. C., Wang, J. Y. & Shi, H. Y., Jul 28 2020, In : Scientific Reports. 10, 1, p. 12555 12555.Research output: Contribution to journal › Article
Open Access